Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 596,482,752
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.43
  • Price/Sales 17.63
  • Price/Cash Flow 42.65
  • Price/Book 40.02
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 24.40% ( -0.22%)
  • Historical Volatility 24.47%
  • IV Percentile 9%
  • IV Rank 8.56%
  • IV High 44.88% on 08/03/23
  • IV Low 22.48% on 06/13/23
  • Put/Call Vol Ratio 0.68
  • Today's Volume 16,456
  • Volume Avg (30-Day) 21,257
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 266,666
  • Open Int (30-Day) 266,649

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.83
  • Number of Estimates 2
  • High Estimate 0.84
  • Low Estimate 0.82
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +31.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.29 +10.82%
on 05/03/24
134.47 -0.04%
on 05/15/24
+10.51 (+8.48%)
since 04/15/24
3-Month
118.30 +13.62%
on 02/21/24
138.28 -2.80%
on 03/07/24
+12.66 (+10.40%)
since 02/15/24
52-Week
75.56 +77.89%
on 07/11/23
138.28 -2.80%
on 03/07/24
+49.70 (+58.66%)
since 05/15/23

Most Recent Stories

More News
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today

Back then, the company wasn't very well known to U.S. investors. That's absolutely not the case these days.

NVO : 134.24 (+0.99%)
Novo Nordisk Bets Up to $600 Million on Ozempic 2.0. Here's Why the Stock Is a Buy.

This company is serious about maintaining its leadership.

NVO : 134.24 (+0.99%)
2 Top Pharma Stocks That Just Keep Getting Better and Better

Both of these businesses are finding traction in a pair of major markets.

LLY : 780.92 (+2.39%)
NVO : 134.24 (+0.99%)
1 'Strong Buy' Dividend Stock to Buy and Hold

Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects....

LLY : 780.92 (+2.39%)
NVO : 134.24 (+0.99%)
How Viking Therapeutics Stock Could 30x

This mid-cap biopharma may one day be a titan of the industry.

LLY : 780.92 (+2.39%)
NVO : 134.24 (+0.99%)
VKTX : 77.00 (+6.21%)
PFE : 28.86 (+1.69%)
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 28.86 (+1.69%)
ABBV : 163.64 (+1.27%)
JNJ : 152.39 (+0.67%)
RHHBY : 31.4600 (+1.65%)
GMAB : 30.31 (+2.64%)
AZN : 77.20 (+0.21%)
DSNKY : 35.1000 (+1.21%)
MRK : 131.41 (+2.14%)
LLY : 780.92 (+2.39%)
NVO : 134.24 (+0.99%)
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

These stocks are both experts in their respective fields.

PFE : 28.86 (+1.69%)
NVO : 134.24 (+0.99%)
EXEL : 21.22 (+1.10%)
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

These pharmaceutical companies are top-notch dividend growth stocks for the future.

NVO : 134.24 (+0.99%)
LLY : 780.92 (+2.39%)
ABBV : 163.64 (+1.27%)
3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy

This is a stock you shouldn't hesitate to buy on the dip.

NVO : 134.24 (+0.99%)
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

NVO : 134.24 (+0.99%)
VKTX : 77.00 (+6.21%)
LLY : 780.92 (+2.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 135.21
2nd Resistance Point 134.11
1st Resistance Point 133.51
Last Price 134.24
1st Support Level 131.81
2nd Support Level 130.71
3rd Support Level 130.11

See More

52-Week High 138.28
Last Price 134.24
Fibonacci 61.8% 114.32
Fibonacci 50% 106.92
Fibonacci 38.2% 99.52
52-Week Low 75.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar